ATAD1 and malaria: With the expanding access to ACT and current changes in malaria epidemiology, the P. falciparum msp1, msp2 and glurp allele frequency/genetic diversity should be monitored regularly to ensure the reliability of the PCR-adjusted treatment outcome.